The Zarqa University Pharmaceutical
Research Center has received ISO 17025 certification from the Jordan Standards
and Metrology Organization (JAS), one of the highest international
accreditation standards for laboratory proficiency and laboratory testing.
This achievement confirms the
center's commitment to applying the highest standards of quality and accuracy
in laboratory testing, enhancing the reliability of its results and
establishing it as a leading institution in pharmaceutical research and
development. It opens up broad horizons for collaboration with academic and
industrial institutions, and supports the expansion of pharmaceutical research
in accordance with international standards.
Prof. Dr. Nidal Al-Ramahi, Zarqa
University President, emphasized that receiving this prestigious certificate
reflects the university's ongoing efforts to achieve the highest standards of
quality and excellence in scientific research and pharmaceutical development.
He pointed out that this accreditation is the result of the Center's tireless
efforts to achieve innovation and leadership in the research field. It will
also enhance the Center's ability to produce high-quality scientific research
and pave the way for more fruitful partnerships with academic and industrial
institutions at the local and international levels.
He added that Zarqa University
continues its tireless efforts to advance scientific research, raise the level
of academic performance, and support innovation, contributing to serving the
community and developing the pharmaceutical sector in Jordan and abroad.
For her part, Dr. Ahlam Al-Kilani, the
Dean of the Faculty of Pharmacy, emphasized that the Center's acquisition of
the ISO 17025 certification represents a qualitative step towards strengthening
its position as an accredited scientific reference. She noted that this
achievement reflects the Faculty and Center's commitment to the highest quality
standards in scientific research, which supports the development of
pharmaceutical industries locally and internationally.
Al-Kilani praised the efforts of the
research team and all those involved with the Center, affirming the Center's
continued efforts to achieve further successes in research and applied fields,
contributing to advancing scientific development and innovation in the
pharmaceutical sector.